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Abstract The purpose of this study was to determine whether
anxiety and mood disorders in late-reproductive-stage women
are related to the serotonin transporter and monoamine oxi-
dase A gene polymorphisms. Research instrument used in this
study were the State-Trait Anxiety Inventory and the UWIST
Mood Adjective Checklist. The 44-bp VNTR polymorphism
in the 5-HTT (SLC 6A4) promoter region and the 30-bp
VNTR polymorphism in the MAO-A promoter region were
analyzed. The study included 345 healthy Polish women in
the late reproductive stage. The mean age of the participants
was 42.3 ± 4.5 years. State anxiety was observed in 16.8 % of
the women and trait anxiety in 14.5 %. There were no statis-
tically significant differences in the mood and the mean levels
of anxiety depending on the presence of the polymorphisms
analyzed in this study. Depressed mood is frequent among
healthy women in the late reproductive stage. Anxiety is def-
initely less common. The study did not demonstrate the rela-
tionship between the 5-HTT and MAO-A gene polymor-
phisms, and the severity of anxiety and mood disorders in
healthy late-reproductive-stage women.
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Introduction
The 2001 Stages of Reproductive AgingWorkshop (STRAW)
standardized the classification of menopause status. A decade
later, the development of the knowledge concerning changes
in a woman’s body resulted in a new, updated STRAW + 10
version.
The study presented here included women who, according
to this classification, were in the late reproductive stage (the
−3 stage), i.e., the stage typified by the onset of a decline in
fecundability and first changes in the menstrual cycle. In ac-
cordance with the STRAW + 10 criteria, this phase is divided
into two subphases: −3b and −3a. The length of the menstrual
cycle in the −3b subphase remains unchanged. What can be
observed, however, is that the levels of anti-Müllerian hor-
mone (AMH) and antral follicle count decrease. The −3a sub-
phase is characterized by a shortening of the menstrual cycle.
Moreover, in the early follicular phase, the level of follicle-
stimulating hormone (FSH) increases, while the levels of other
biomarkers of ovarian aging decrease (Harlow et al. 2012).
The level of FSH >30 ml U/ml is regarded as critical and
marked by the lack of ovarian follicles in the ovaries. In this
period, the level of estradiol decreases dramatically (40–
400 pg/ml depending on the phase of the menstrual cycle
before menopause to 20–30 pg/ml after menopause)
(Baranowski 2004).
Even though they can be related to the menopausal period,
symptoms such as depressed mood, nervous tension, and con-
centration problems are not treated as its typical signs (Banger
2002). Still, as opinion surveys show, a vast majority of wom-
en expects the occurrence of these symptoms and is afraid of
them (Podgórska 2003). Mood disorders more often affect
women than men. As some authors (Krogulski 2004) claim,
the perimenopausal period entails escalation of symptoms due
to the coexistence of biological and nonbiological factors.
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Many women feel worried thinking about approaching men-
opause. They are afraid of physical complaints, but, above all,
they treat the climacteric as the end of a full-value life and the
beginning of old age (Sprawka et al. 2008).
Women are at a two to three times higher risk of developing
anxiety disorders, especially in the perimenopausal period, than
men. The study conducted byWeiss et al. (2015) showed that a
woman’s level of anxiety was the strongest predictor of her
likelihood of having severe depression. The etiology of panic
disorder includes the serotonergic, noradrenergic, gamma-
aminobutyric acid (GABA), and neuroanatomic models, as
well as the genetic hypothesis (the presence of strong stress
factors is necessary). In women, environmental and genetic
factors can increase anxiety and mood changes. Genes in-
volved in serotonergic pathways are regarded as candidate
genes due to the documented role of serotonin (5-HT) in the
etiopathogenesis of mood disorders. One of themost frequently
analyzed genes of this group is SLC6A4—a single gene located
on the 17q12 chromosome, encoding the serotonin transporter
(5-HTT). The polymorphism of this gene is characterized by
the insertion or deletion of a 44-bp fragment and entails differ-
ent gene transcriptional activity. A short allele (allele with de-
letion of a 44-bp sequence) is characterized by a three times
lower transcriptional activity than a long allele (allele with in-
sertion of a 44-bp sequence) (Hauser and Dmitrzak-Węglarz
2010). Available results show that the presence of the s allele of
this gene is associated with a higher neuroticism and the devel-
opment of anxiety and mood disorders (Jurczak et al. 2015;
Stein et al. 2009). What is more, when combined with adverse
environmental factors, it may increase the probability of mood
disorders related to stressful life events (Caspi and Moffitt
2006; Wilhelm et al. 2006; Jacobs et al. 2006; Paaver et al.
2008). Carriers of the s allele of this gene are more susceptible
of affective disorders and anxiety states (Ebstein 2006; Stein
et al. 2008). The monoamine oxidase A (MAO-A) gene that
encodes the MAO-A enzyme may be also responsible for an
inclination to depression. Sabol et al. (1998) were the first to
describe the uMAO-A polymorphism, which is a variable-
number tandem repeat (VNTR) polymorphism in the uMAO-
A promoter region. It consists of a 30-bp repeated sequence that
may be present in 3, 3.5, 4, or 5 copies (Black et al. 1991). The
B3^ allele is associated with a lower transcriptional activity of
the gene, while the B3.5,^ B4,^ and B5^ alleles are related to a
higher MAO-A activity (Denney et al. 1999). Interesting con-
clusions were drawn from the research which demonstrated a
U-shaped relationship between behavior and theMAO activity
in thrombocytes. It was found that both individuals with a low
and those with a highMAO activity show higher impulsivity in
neuropsychological tests (Klinteberg et al. 1987). They are sig-
nificantly more likely to develop nicotine addiction (Harro et al.
2004) and anxiety disorders (Schalling et al. 1987).
Ovarian hormones (FSH, AMH, E2) play a key role in
sustaining proper brain function and the brain’s response to
environmental stimuli (Toffoletto et al. 2014). It is a common
belief that ovarian hormones may be essential for the emer-
gence of differences between individuals of both sexes in the
incidence of mood and anxiety disorders. Nevertheless, mech-
anisms underlying this phenomenon have not yet been fully
explicated. It is assumed that ovarian hormones may contrib-
ute to the regulation of mood through the mediating effect of
psychological stress, which often precedes episodes of depres-
sion. It may result in mood disorders, which are especially
common among women (Albert et al. 2015).
The aim of this study was to investigate how mood and
anxiety of late-reproductive-stage women are related to the 5-
HTT and MAO-A gene polymorphisms.
Materials and methods
The study involved 345 healthy, late-reproductive-stage wom-
en from northwest Poland. The criteria for inclusion in the
study were as follows: no endocrine disorders, no neoplastic
diseases, and no psychiatric problems. The criteria for exclu-
sion from the study were abnormal smear test results, diagno-
sis of thyroid diseases and/or diabetes, diagnosis of neoplastic
diseases, and diagnosis of mental diseases.
Women with Axis I mental disorders according to the ICD-
10 classification were excluded from the study using the
PRIME-MD questionnaire and a psychiatric examination
(Spitzer et al. 1999). In all women, the levels of AMH and
FSH were determined. On the basis of the results, the women
were categorized as being in the late reproductive stage.
All participants gave their informed consent to participate
in the research. The study was conducted in accordance with
the Declaration of Helsinki, and the protocol was approved by
the Bioethical Commission of the Pomeranian Medical
University in Szczecin (permission number KB-0012/12/12).
Assessments
The first part of this study was survey-based and conducted
using the following standardized research tools: the State-Trait
Anxiety Inventory (STAI) and the UWIST Mood Adjective
Checklist (UMACL).
STAI consists of two parts, each including a set of 20 ques-
tions. The first part, STAI (X-1), is used to determine the level
of anxiety understood as a transitory and situation-dependent
status of a person. The second part, STAI (X-2), serves for
measuring anxiety regarded as a rather stable personality trait
(Sosnowski et al. 2006). Respondents choose one of four pos-
sible answers to each statement. The level of anxiety is
expressed as the number of points obtained through summing
up scores for separate answers. For each part of the question-
naire, the respondents may obtain a score of 20 to 80 points.
Raw data are converted into standardized results for gender
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and age (stens). In our study, we used the 10-unit sten scale
interpreted as follows:
√Scores of 1–4—low results (a low level of anxiety as a
trait and a state)
√Scores of 5–6—average results (an average level of anx-
iety as a trait and a state)
√Scores of 7–10—high results (a high level of anxiety as
a trait and a state)
A high score for state anxiety suggests that a person is
under stress caused by a difficult life situation. A high score
for anxiety as a trait, on the other hand, implies a permanent
predisposition to react with anxiety to life situations
(Sosnowski et al. 2006).
UMACL has been developed to measure mood understood
as an affective experience of moderate duration not related
with the object or related with a quasi-object (Goryńska
2005). It consists of a sheet with 29 printed adjectives.




The raw result of each UMACL subscale is the sum of
points for the items included in this subscale. The answers
are weighed on a four-point scale. A raw result of the hedonic
tone subscale may range from 10 to 40 points, the tense arous-
al subscale from 9 to 36 points, and the energetic arousal
subscale from 10 to 40 points. Raw points were converted into
stens by using the formula by Goryńska (2005).
The second stage of the study was based on genetic analy-
sis, in which DNAwas isolated fromwhole blood by a salting-
out method according to Miller et al. (1988). DNA polymor-
phisms were identified using a polymerase chain reaction
(PCR). The purpose of the analysis was to amplify the frag-
ment which consisted of two to five repetitions of the 30-bp
VNTR polymorphism in the MAO-A promoter region. The
following primers were used F: 5′ CCC AGG CTG CTC
CAG AAA 3′ and R: 5′ GGA CCT GGG CAG TTG TGC
3′. The PCR consisted of an initial denaturing step at 95 °C for
3 min, followed by 34 cycles of denaturing at 94 °C for 40 s,
annealing at 57 °C for 35 s, and polymerization at 72 °C for
50 s, with a final elongation step at 72 °C for 10 min.
The sizes of the amplified fragments were as follows: 239,
209, 226, and 269 bp. In the analysis of the 5-HTT polymor-
phism, the fragment including the 44-bp ins/del in the regula-
tory sequence was amplified. The following primer sequences
were used:HTT F, 5′GGCGTTGCCGCT CTGAATGC 3′;
andHTT R, 5′GAGGGACTGAGCTGGACAACCAC 3′.
The PCR consisted of an initial denaturing step at 94 °C for
5 min, followed by 30 cycles of denaturing at 94 °C for 55 s,
annealing at 55 °C for 50 s, and polymerization at 72 °C for
60 s, with a final elongation step at 72 °C for 10min. The sizes
of the amplified fragments were 484 and 528 bp. The PCR
products were electrophoresed on 3 % agarose gel, which was
followed by ethidium bromide staining to detect the alleles
(Miller et al. 1988).
FSH and AMH levels were determined as the third stage of
the study. Venous blood samples were collected from women in
the follicular phase of the menstrual cycle using a closed system
(Vacutainer) after the women gave their consent to this proce-
dure. The blood was drawn in the treatment room and delivered
to the laboratory in accordance with the relevant rules and pro-
cedures. The levels of FSH and AMH were determined in a
laboratory accredited with ISO 9001:2008 quality certification.
The FSH ranges accepted in the study as normal were FSH
follicular levels, namely 3.5–12.5 mlU/ml.
Statistical analyses
A statistical analysis was performed using STATISTICA 7.1 PL.
The chi-squared independence test was employed to verify the
null hypothesis about the independence of the variables.
Spearman’s rank R correlation coefficient was applied to test
the strength of a relationship between the ordinal variables.
The Hardy-Weinberg principle was p = 0.952 for MAO-A
and p = 1 for 5-HTT.
The Shapiro-Wilk test for normality demonstrated the lack
of a normal distribution of the variables analyzed.
Independent variables were analyzed using the Mann-
Whitney U test.
The results were regarded as statistically significant when
p ≤ 0.05. The level of statistical significance was set at
p ≤ 0.05.
The level of statistical significance was set at α = 0.05. The
power calculated for all genetic tests exceeded 0.95
(power > 0.95).
Results
The women included in the study were aged 42.3 ± 4.5 years on
average. More than half of them (75.1 %) had completed higher
education; 22.6 %, secondary education; 2.0 %, vocational edu-
cation; and 0.3%, primary education. Themajority of thewomen
lived in cities with a population greater than 100,000 residents
(72.5 %); 12.0 and 2.9 % lived in rural areas and towns with a
population of up to 10,000, respectively; and the remainder
(12.8 %) lived in towns with less than 100,000 residents. The
vast majority of the participants had life partners (75.1 %).
In the analysis of anxiety as a state (STAI X1), the median
was 4 stens and the interquartile range (IQR) 2 stens. In the
analysis of anxiety as a trait (STAI X2), the median was the
same, and the IQR was 3 stens.
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In the mood analysis performed using a standardized in-
strument, UMACL, the median and the IQR for hedonic tone
were 2 stens and 1 sten, respectively, and they were identical
as for energetic arousal. The median for tense arousal was 8
stens and the IQR 1 sten.
In the study group of women, average hormone levels were
as follows: E2 80 pg/ml, IQR 96.1, FSH 6.4ml U/ml, IQR 3.5,
AMH 1.33 ng/ml, IQR 2.34.
There was no statistically significant relationship be-
tween the mood (hedonic tone level, tense arousal, ener-
getic arousal) of postmenopausal women according to
UMACL and the distribution of genotypes and the fre-
quency of alleles of the 44-bp VNTR polymorphism in
the 5-HTT (SLC 6A4) promoter region and the 30-bp
VNTR polymorphism in the MAO-A promoter region
(p > 0.05) (Table 1).
Analysis of the data did not demonstrate statistically signif-
icant differences in the levels of state anxiety (STAI X1) and
trait anxiety (STAI X2) according to STAI depending on the
distribution of genotypes of the 44-bp VNTR polymorphism in
the 5-HTT (SLC 6A4) promoter region and the 30-bp VNTR
polymorphism in the MAO-A promoter region (p > 0.05). The
3/5 genotypes were not shown in the table (Table 2).
No statistically significant relationships between age and
hormonal factors andmood according to UMACL and anxiety
according to STAI were demonstrated (Table 3).
Discussion
The most frequently analysed molecules engaged in the regu-
lation of the level of serotonin in the brain are serotonin trans-
porter (5-HTT), responsible for the transport of this hormone
from the extracellular space, and monoamine oxidase A
(MAO-A), a key enzyme taking part in the degradation of
serotonin. Genetic variants in genes encoding these proteins
vary in transcriptional activity. Numerous scientific reports
suggest that there are relationships between genetic variants
in these genes, specific behavioral traits, and psychiatric dis-
orders (Nordquist and Oreland 2010).
The 5-HTTLPR polymorphism is the most widely investi-
gated genetic variant used in psychiatric research (Mushtaq
et al. 2014).
Sen et al. (2004) noticed that a large number of studies are
based on the assumption that personality traits, such as neu-
roticism measured with the Neuroticism-Extraversion-
Openness (NEO) Inventory and harm avoidance assessedwith
the Temperament and Character Inventory (TCI), are related
to genetic factors. These authors conducted a meta-analysis
which included a total number of 5629 participants, and found
suggestive evidence for the connection between the presence
of the 5-HTTLPR s allele and lower levels of anxiety-related
personality traits (p = 0.087). Nevertheless, they emphasize
the diversity of findings concerning these issues, which main-
ly results from the use of different research instruments. When
the analysis was stratified by inventory type, the authors no-
ticed a strong relationship between the 5-HTTLPR and the
level of neuroticism as gauged by the NEO Inventory, while
the relationship between this gene polymorphism and harm
avoidance according to the TCI/Tridimensional Personality
Questionnaire (TPQ) was not statistically significant.
The meta-analysis conducted by Schinka et al. (2004)
showed that the level of anxiety was not related to the pres-
ence of the s/s genotype of the 5-HTTLPR polymorphism. The
same study, however, demonstrated a small but significant
relationship between this polymorphism and the level of
Table 1 Analysis of the relationship between the women’s mood according to UMACL and the distribution of genotypes of the 44-bp VNTR
polymorphism in the 5-HTT (SLC 6A4) promoter region and the 30-bp VNTR polymorphism in the MAO-A promoter region
UMACL (N = 345) 5-HTT
Genotypes Depending on genotypes
l/l (n = 132) l/s (n = 163) s/s (n = 50) l/l vs. l/s + s/s s/s vs. l/l + l/s l/l vs. s/s
M (IQR) M (IQR) M (IQR) Z p Z p Z p
TH 2 (2) 2 (2) 2 (1) −0.445 0.656 −1.116 0.265 −1.083 0.279
PN 8 (1) 8 (1) 8 (1) 0.910 0.363 1.100 0.271 1.283 0.200
PE 2 (1) 1 (1) 2 (1) 0.287 0.774 −1.353 0.176 −0.945 0.345
UMACL (N = 339) MAO-A
Genotypes Depending on genotypes
4/4 (n = 142( 4/3 (n = 153( 3/3 (n = 44( 4/4 vs. 4/3 + 3/3 3/3 vs. 4/4 + 4/3 4/4 vs. 3/3
M (IQR) M (IQR) M (IQR) Z p Z p Z p
TH 2 (1) 2 (1) 2 (1,5) 0.514 0.607 0.834 0.404 0.831 0.406
PN 8 (1) 8 (1) 9 (1) −0.207 0.836 −1.424 0.154 −1.221 0.222
PE 2 (1) 2 (1) 2 (1) −0.726 0.468 0.072 0.942 −0.207 0.836
N number of participants, n number of participants in genotypic subgroup,Mmedian, IQR interquartile range, ZMann-Whitney U test statistics, p level
of significance, TH hedonic tone, PN tense arousal, PE energetic arousal
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neuroticism assessed using the five-factor model developed
by Costa and McCrae (Schinka et al. 2004).
Munafò et al. (2005) reported on findings that were oppo-
site to the results of similar previous meta-analyses. They
pointed to statistically significant differences in the levels of
personality traits predisposing to anxiety (such as harm avoid-
ance measured with the TCI/TPQ) in carriers of the s/s geno-
type and the l/l genotype of the 5-HTTLPR. A similar relation-
ship was not observed in the case of neuroticism assessed with
the NEO Inventory. These authors believe that the relationship
between the 5-HTTLPR and anxiety-related traits cannot be
excluded, but it is probably small (Munafò et al. 2005).
It was proved that carriers of the 5-HTT s allele were at a
higher risk of anxiety disorders, but this association was only
confirmed in representatives of the Caucasian race. Quite an
opposite situation was observed among Asian people, whose
risk of this disorder was higher if they had the ‘l’ allele (Long
et al. 2013). According to other studies, being a carrier of the
‘S’ genotype raises a risk of the development of posttraumatic
stress disorder (PTSD)—a type of anxiety disorder which only
occurs when a person is exposed to strong environmental
stress (Kilpatricik et al. 2007).
Most analyses regarding the frequency of particular geno-
types in a population show that the most common is the l/s
genotype. Such observation was made in the studies of
Mushtaq et al. (2014) (55 % of the control group), Bellivier
et al. (2000) (52.7 %), Lee et al. (2005) (65 %), and Mann
et al. (2000) (57%). In our study, a group of people with the l/s
genotype was slightly smaller and included 47.25 % of all
participants.
In many scientific investigations, the s/s genotype is con-
siderably more common among people with high levels of
anxiety. As many as 73.3 % of people with diagnosed anxiety
disorders from India had this genotype (Mushtaq et al. 2014).
Our study did not confirm a higher frequency of the s/s geno-
type in people with high anxiety levels—merely 32.76 % of
them were its carriers. Nonetheless, it must be underlined that
none of the individuals included in our study had been diag-
nosed as having mental disorders or had received psychiatric
treatment.
The research carried out in India demonstrated that as
many as 93 % of patients with anxiety disorders had ei-
ther mild or moderate depression, and 40 % of patients
with diagnosed depression suffered from anxiety disor-
ders. Considering divergent reports on the association be-
tween an increased inclination to depression and the pres-
ence of the s/s genotype and the s allele of the 5-HTTLPR,
which either suggest that such a connection exists (Lee
et al. 2005; Mann et al. 2000; Murtaza et al. 2006) or that
it does not (Mushtaq et al. 2014; Margoob and Mustaque
2011; Risch et al. 2009); these issues must be further
investigated.
Table 2 Analysis of the relationship between anxiety as a state (STAI X1) and anxiety as a trait (STAI X2) according to STAI and the distribution of
genotypes of the 44-bp VNTR polymorphism in the 5-HTT (SLC 6A4) promoter region and the 30-bp VNTR polymorphism in the MAO-A promoter
region
STAI (N = 345) 5-HTT
Genotypes Depending on genotypes
l/l (n = 132) l/s (n = 163) s/s (n = 50) l/l vs. l/s + s/s s/s vs. l/l + l/s l/l vs. s/s
M (IQR) M (IQR) M (IQR) Z p Z p Z p
STAI X1 4 (2) 4 (2) 4 (2) −0.180 0.857 −0.991 0.322 −0.877 0.381
STAI X2 4 (3) 4 (3) 4 (3) −0.412 0.680 −0.684 0.494 −0.717 0.473
STAI (N = 339) MAO-A
Genotypes Depending on genotypes
4/4 (n = 142) 4/3 (n = 153) 3/3 (n = 44) 4/4 vs. 4/3 + 3/3 3/3 vs. 4/4 + 4/3 4/4 vs. 3/3
M (IQR) M (IQR) M (IQR) Z p Z p Z p
STAI X1 4 (2) 4 (2) 4 (3) 0.294 0.769 0.838 0.402 0.800 0.424
STAI X2 4 (3) 4 (3) 4 (3) −0.007 0.994 −0.107 0.915 −0.108 0.914
N number of participants, n number of participants in genotypic subgroup,Mmedian, IQR interquartile range, ZMann-Whitney U test statistics, p level
of significance
Table 3 Spearman’s rank correlation coefficient
N = 345 Age AMH FSH E2
R R R R
Mood according to UMACL
TH −0.020 0.041 0.002 −0.089
PN 0.066 −0.060 0.006 0.042
PE −0.011 0.097 −0.024 −0.035
Anxiety according to STAI
STAI X1 0.030 −0.000 0.45 −0.095
STAI X2 −0.012 0.005 0.040 −0.042
There is no statistically significant correlation relationship between the
variables analyzed in the study
TH hedonic tone, PN tense arousal, PE energetic arousal
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The MAO-A enzyme, which in humans is encoded by
the MAO-A gene, may metabolize serotonin and thus de-
crease its activity (Caspi et al. 2002). On a biological
level, it has been proved that high activity of the MAO-
A gene leads to the degradation of serotonin. Dysfunction
of the serotonin system, on the other hand, is a part of the
pathophysiology of affective disorders, including anxiety
disorders (Voltas et al. 2015). It is confirmed that a func-
tional 30-bp ins/del polymorphism in the MAO-A gene
may be present in 2, 3, 3.5, 4, or 5 copies. The 4-repeat
allele contributes to a higher MAO-A activity. The study
conducted in 2003 by Tadic et al. (2003) was the first to
prove empirically that generalized anxiety disorders are
related to the presence of the MAO-A gene polymorphism.
MAO-A is regarded as an anxiety candidate gene due to
efficiency ofMAO inhibitors in treatment of anxiety disorders
(Libert et al. 2011).
The study of 569 high school students demonstrated a sig-
nificant association between the MAO-A gene polymorphism
and anxiety levels. The results confirmed that the 4-repeat
allele of the MAO-A gene was related to a higher level of
anxiety (Liu and Lu 2013). Longitudinal research conducted
in Spain on a group of 245 students confirmed a likely rela-
tionship between a variant of the MAO-A gene and anxiety
symptoms (Voltas et al. 2015). A cohort study conducted by
Chen et al. (2013) demonstrated that the low MAO-A expres-
sion statistically significantly increased the level of satisfac-
tion among women.
The analysis of state anxiety and trait anxiety among pre-
menopausal and postmenopausal women (mean age 47.7 ±
4.4) conducted in Turkey did not demonstrate statistically sig-
nificant differences; nevertheless, the level of anxiety in a
group of older women was slightly higher. In both groups,
the level of anxiety was high (STAI-I 50.4 ± 9.1 vs. 47.5 ±
8.3; STAI-II 47.5 ± 9.1 vs. 45.4 ± 7.5 in postmenopausal and
premenopausal women, respectively) (Sagsöz et al., 2001).
The results reported by Pearlstein et al. (1997) show that the
severity of depressive symptoms and the level of anxiety in-
crease several years before menopause. Our study did not
reveal any significant relationships between particular geno-
type variants of theMAO-A gene and the level of anxiety as a
state or as a trait in a group of premenopausal women (mean
age 42.3 ± 4.5 years).
The analysis of patients with diagnosed and treated mood
disorders in India revealed that the most common genotype in
these people was l/s (43.3 %). The l/l genotype was found in
33.3 % (Mushtaq et al. 2014). In our study, a similar distribu-
tion of genotypes was observed in healthy individuals with
depressed mood: the l/s genotype was observed in 46.7 %
and the s/s genotype in 39.3 % of the participants.
To determine the relationship between sex hormones
and a tendency to develop anxiety and mood disorders,
Albert et al. analyzed mood and the activity of the brain
as a response to psychological stress. The study involved
healthy, normally menstruating women in the phases of
the menstrual cycle marked by high or low levels of es-
tradiol. Significant differences in the activity of the brain
in the situation of exposure to psychological stress were
observed between the two groups. Women with high
levels of estradiol showed significantly less deactivation
in limbic regions than their counterparts with low levels
of this hormone. The results show that in normally men-
struating, healthy women in the premenopausal period,
high levels of estradiol attenuate the brain activation
changes and negative reaction to psychological stress
(Albert et al. 2015). Toffoletto et al.’s (2014) review of
recent studies concerning the effects of sex hormones on
neural substrates of emotional and cognitive reactions
suggests that sex hormones may influence cortical and
subcortical regions, which results in the modulation of
emotional and cognitive processes. The study described
in this article did not confirm the relationship between
the levels of sex hormones (AMH, FSH, and E2) and
the subjective perception of mood and anxiety experi-
enced by the participants.
Conclusions
1. In the study, anxiety and mood were not related to the 5-
HTT and MAO-A gene polymorphisms in healthy, late-
reproductive-stage women.
2. Mood and anxiety were not significantly related to hor-
monal factors in the study group of healthy, late-
reproductive-stage women.
Limitations
Considering the results obtained, it seems reasonable to carry
out more detailed analysis of the influence of psychological
and social factors, which may be essential for the severity of
anxiety and mood disorders in healthy women. The findings
in this study emphasize that the relationship between anxiety
and its related mood disorders is complex and require further
study. We plan to continue our research in order to observe the
above-described relationships. It should be emphasized that
our study involved healthy women only, and though it did
not confirm the connection between genetic and hormonal
factors and the severity of anxiety and mood disorders, it
can be used in a comparative study of women suffering from
disorders.
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